Literature DB >> 17052191

The role of ubiquitin in neurotrophin receptor signalling and sorting.

M W Wooten1, T Geetha.   

Abstract

NGF (nerve growth factor) binding to TrkA (tropomyosin receptor kinase A) induces dimerization, autophosphorylation and internalization of the receptor to signalling vesicles for delivery of differentiation signals. TrkA interacts with p75 receptor through the p62-TRAF-6 (tumour-necrosis-factor-receptor-associated factor 6) complex bridging the two receptors. The atypical protein kinase C is activated and recruited to the receptor complex as well. TrkA is Lys63-polyubiquitinated on Lys485 by the E3 (ubiquitin ligase), TRAF-6, and E2 (ubiquitin-conjugating enzyme), UbcH7. Inhibition of polyubiquitination has been observed to interrupt signalling and internalization. Furthermore, an absence of p62 prevents endosomal localization and signalling. Altogether, these findings reveal Lys63-linked polyubiquitin chains and the shuttling protein p62 co-ordinately regulate TrkA internalization, trafficking and sorting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052191     DOI: 10.1042/BST0340757

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  3 in total

1.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

2.  The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.

Authors:  Estelle Chamoux; Julie Couture; Martine Bisson; Jean Morissette; Jacques P Brown; Sophie Roux
Journal:  Mol Endocrinol       Date:  2009-07-09

3.  p62/SQSTM1 promotes rapid ubiquitin conjugation to target proteins after endosome rupture during xenophagy.

Authors:  Megumi Tsuchiya; Hidesato Ogawa; Takako Koujin; Chie Mori; Hiroko Osakada; Shouhei Kobayashi; Yasushi Hiraoka; Tokuko Haraguchi
Journal:  FEBS Open Bio       Date:  2018-02-07       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.